Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Considering Benzbromarone as First-Line Therapy for Gout

  |  

For full study details, including source material, refer to the full article.

Excerpted and adapted from:

ADVERTISEMENT
SCROLL TO CONTINUE

Yan F, Xue X, Lu J, et al. Superiority of low-dose benzbromarone to low-dose febuxostat in a prospective, randomized comparative effectiveness trial in gout patients with renal uric acid underexcretion. Arthritis Rheumatol. 2022 Dec;74(12).

Related Articles